Annual Total Assets
$1.14 B
+$374.25 M+48.89%
September 30, 2024
Summary
- As of February 12, 2025, ARWR annual total assets is $1.14 billion, with the most recent change of +$374.25 million (+48.89%) on September 30, 2024.
- During the last 3 years, ARWR annual total assets has risen by +$429.65 million (+60.50%).
- ARWR annual total assets is now at all-time high.
Performance
ARWR Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$1.14 B
+$256.04 M+28.97%
September 30, 2024
Summary
- As of February 12, 2025, ARWR quarterly total assets is $1.14 billion, with the most recent change of +$256.04 million (+28.97%) on September 30, 2024.
- Over the past year, ARWR quarterly total assets has increased by +$184.65 million (+19.33%).
- ARWR quarterly total assets is now at all-time high.
Performance
ARWR Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ARWR Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.9% | +19.3% |
| 3 y3 years | +60.5% | +60.5% |
| 5 y5 years | +225.8% | +60.5% |
ARWR Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.7% | at high | +82.0% |
| 5 y | 5-year | at high | +225.8% | at high | +128.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Arrowhead Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $1.14 B(+48.9%) | $1.14 B(+29.0%) |
| Jun 2024 | - | $883.76 M(-7.5%) |
| Mar 2024 | - | $955.15 M(+52.5%) |
| Dec 2023 | - | $626.29 M(-18.2%) |
| Sep 2023 | $765.55 M(+10.6%) | $765.55 M(-3.8%) |
| Jun 2023 | - | $795.86 M(-10.7%) |
| Mar 2023 | - | $891.31 M(-0.0%) |
| Dec 2022 | - | $891.49 M(+28.8%) |
| Sep 2022 | $691.94 M(-2.6%) | $691.94 M(-8.0%) |
| Jun 2022 | - | $751.78 M(+6.9%) |
| Mar 2022 | - | $703.58 M(+10.2%) |
| Dec 2021 | - | $638.54 M(-10.1%) |
| Sep 2021 | $710.15 M(+35.9%) | $710.15 M(-3.4%) |
| Jun 2021 | - | $734.93 M(-2.9%) |
| Mar 2021 | - | $756.79 M(+51.6%) |
| Dec 2020 | - | $499.25 M(-4.5%) |
| Sep 2020 | $522.50 M(+49.4%) | $522.50 M(-6.0%) |
| Jun 2020 | - | $555.73 M(-1.0%) |
| Mar 2020 | - | $561.08 M(-4.5%) |
| Dec 2019 | - | $587.60 M(+68.0%) |
| Sep 2019 | $349.85 M(+213.5%) | $349.85 M(+3.9%) |
| Jun 2019 | - | $336.83 M(+0.9%) |
| Mar 2019 | - | $333.94 M(-2.1%) |
| Dec 2018 | - | $340.95 M(+205.5%) |
| Sep 2018 | $111.61 M(+7.3%) | $111.61 M(-1.1%) |
| Jun 2018 | - | $112.90 M(-11.1%) |
| Mar 2018 | - | $127.00 M(+44.0%) |
| Dec 2017 | - | $88.22 M(-15.2%) |
| Sep 2017 | $104.02 M(-18.8%) | $104.02 M(-9.6%) |
| Jun 2017 | - | $115.08 M(-9.3%) |
| Mar 2017 | - | $126.87 M(-12.1%) |
| Dec 2016 | - | $144.26 M(+12.5%) |
| Sep 2016 | $128.18 M(-3.1%) | $128.18 M(+49.9%) |
| Jun 2016 | - | $85.53 M(-9.6%) |
| Mar 2016 | - | $94.61 M(-15.1%) |
| Dec 2015 | - | $111.38 M(-15.8%) |
| Sep 2015 | $132.27 M(-27.7%) | $132.27 M(-8.9%) |
| Jun 2015 | - | $145.19 M(-10.6%) |
| Mar 2015 | - | $162.38 M(+0.1%) |
| Dec 2014 | - | $162.14 M(-11.3%) |
| Sep 2014 | $182.82 M(+389.7%) | $182.82 M(-7.0%) |
| Jun 2014 | - | $196.62 M(-3.0%) |
| Mar 2014 | - | $202.64 M(+118.6%) |
| Dec 2013 | - | $92.69 M(+148.3%) |
| Sep 2013 | $37.33 M(+125.9%) | $37.33 M(-10.0%) |
| Jun 2013 | - | $41.49 M(+234.1%) |
| Mar 2013 | - | $12.42 M(-18.5%) |
| Dec 2012 | - | $15.23 M(-7.8%) |
| Sep 2012 | $16.53 M | $16.53 M(+0.2%) |
| Jun 2012 | - | $16.49 M(-17.9%) |
| Mar 2012 | - | $20.08 M(-12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $23.06 M(+45.1%) |
| Sep 2011 | $15.89 M(+28.6%) | $15.89 M(+19.6%) |
| Jun 2011 | - | $13.29 M(-12.8%) |
| Mar 2011 | - | $15.24 M(+0.3%) |
| Dec 2010 | - | $15.19 M(+22.9%) |
| Sep 2010 | $12.35 M(+60.4%) | $12.35 M(-15.4%) |
| Jun 2010 | - | $14.60 M(+88.1%) |
| Mar 2010 | - | $7.76 M(-15.0%) |
| Dec 2009 | - | $9.13 M(+18.5%) |
| Sep 2009 | $7.70 M(-55.4%) | $7.70 M(-6.1%) |
| Jun 2009 | - | $8.20 M(-19.4%) |
| Mar 2009 | - | $10.17 M(-33.9%) |
| Dec 2008 | - | $15.39 M(-10.8%) |
| Sep 2008 | $17.26 M(-42.2%) | $17.26 M(-9.8%) |
| Jun 2008 | - | $19.13 M(-22.9%) |
| Mar 2008 | - | $24.82 M(-19.1%) |
| Dec 2007 | - | $30.66 M(+2.7%) |
| Sep 2007 | $29.85 M(-13.5%) | $29.85 M(-18.7%) |
| Jun 2007 | - | $36.72 M(+36.5%) |
| Mar 2007 | - | $26.90 M(-21.8%) |
| Dec 2006 | - | $34.39 M(-0.4%) |
| Sep 2006 | $34.53 M(+18.9%) | $34.53 M(-14.9%) |
| Jun 2006 | - | $40.58 M(-10.0%) |
| Mar 2006 | - | $45.09 M(+74.2%) |
| Dec 2005 | - | $25.88 M(-10.9%) |
| Sep 2005 | $29.04 M(+143.7%) | $29.04 M(-5.4%) |
| Jun 2005 | - | $30.71 M(+110.9%) |
| Mar 2005 | - | $14.56 M(+45.3%) |
| Dec 2004 | - | $10.02 M(-15.9%) |
| Sep 2004 | $11.92 M(+686.1%) | $11.92 M(-1.9%) |
| Jun 2004 | - | $12.15 M(+5.6%) |
| Mar 2004 | - | $11.51 M(+440.9%) |
| Dec 2003 | - | $2.13 M(+40.4%) |
| Sep 2003 | $1.52 M(+2283.5%) | $1.52 M(+3188.3%) |
| Jun 2003 | - | $46.10 K(+6.5%) |
| Mar 2003 | - | $43.30 K(-9.4%) |
| Dec 2002 | - | $47.80 K(-24.8%) |
| Sep 2002 | $63.60 K(+37.4%) | $63.60 K(-39.5%) |
| Jun 2002 | - | $105.10 K(+109.8%) |
| Mar 2002 | - | $50.10 K(+3.1%) |
| Dec 2001 | - | $48.60 K(+5.0%) |
| Sep 2001 | $46.30 K(-28.9%) | $46.30 K(-20.2%) |
| Jun 2001 | - | $58.00 K(-0.5%) |
| Mar 2001 | - | $58.30 K(-5.5%) |
| Dec 2000 | - | $61.70 K(-5.2%) |
| Sep 2000 | $65.10 K(-20.9%) | $65.10 K(-2.4%) |
| Jun 2000 | - | $66.70 K(-3.9%) |
| Mar 2000 | - | $69.40 K(-1.7%) |
| Dec 1999 | - | $70.60 K |
| Sep 1999 | $82.30 K(-4.4%) | - |
| Sep 1998 | $86.10 K(-20.1%) | - |
| Sep 1997 | $107.70 K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual total assets year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly total assets year-on-year change?
What is Arrowhead Pharmaceuticals annual total assets?
The current annual total assets of ARWR is $1.14 B
What is the all time high annual total assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total assets is $1.14 B
What is Arrowhead Pharmaceuticals annual total assets year-on-year change?
Over the past year, ARWR annual total assets has changed by +$374.25 M (+48.89%)
What is Arrowhead Pharmaceuticals quarterly total assets?
The current quarterly total assets of ARWR is $1.14 B
What is the all time high quarterly total assets for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total assets is $1.14 B
What is Arrowhead Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, ARWR quarterly total assets has changed by +$184.65 M (+19.33%)